(Q38594107)

4 September 2017

Social Media and Myeloproliferative Neoplasms (MPN)--Focus on Twitter and the Development of a Disease-specific Community: #MPNSM. (English)

1 reference

4 September 2017

0 references

0 references

1

Naveen Pemmaraju

1 reference

4 September 2017

Vikas Gupta

2

1 reference

4 September 2017

Ruben Mesa

series ordinal

3

1 reference

4 September 2017

Michael A Thompson

series ordinal

4

1 reference

4 September 2017

28 September 2015

1 reference

Current hematologic malignancy reports

4 September 2017

1 reference

4 September 2017

10

1 reference

4 September 2017

4

1 reference

4 September 2017

413-420

1 reference

https://scigraph.springernature.com/pub.10.1007/s11899-015-0287-9

4 September 2017

0 references

cites work

Scientists in the Twitterverse.

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Social media, text messaging, and email-preferences of asthma patients between 12 and 40 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Take two aspirin and tweet me in the morning: how Twitter, Facebook, and other social media are reshaping health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Dissemination of health information through social networks: twitter and antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Twitter Social Media is an Effective Tool for Breast Cancer Patient Education and Support: Patient-Reported Outcomes by Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Pandemics in the age of Twitter: content analysis of Tweets during the 2009 H1N1 outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Detecting themes of public concern: a text mining analysis of the Centers for Disease Control and Prevention's Ebola live Twitter chat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Trends in twitter use by physicians at the american society of clinical oncology annual meeting, 2010 and 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Social media and palliative medicine: a retrospective 2-year analysis of global Twitter data to evaluate the use of technology to communicate about issues at the end of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

From Philadelphia-Negative to JAK2-Positive: Effect of Genetic Discovery on Risk Stratification and Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Somatic mutations of calreticulin in myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Therapy for myeloproliferative neoplasms: when, which agent, and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

The use of social-networking sites in medical education.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Understanding the factors that influence the adoption and meaningful use of social media by physicians to share medical information

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

The social media revolution is changing the conference experience: analytics and trends from eight international meetings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Criteria for social media-based scholarship in health professions education

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Web-based social media for professional medical education: Perspectives of senior stakeholders in the nursing home sector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Social media and medical education: Exploring the potential of Twitter as a learning tool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Creating, curating, and sharing online faculty development resources: the medical education in cases series experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Social media in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Quality of life in MPN comes of age as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Ruxolitinib versus standard therapy for the treatment of polycythemia vera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Treating Myeloproliferation--On Target or Off?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Practical guidance: the use of social media in oncology practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Using social media to learn and communicate: it is not about the tweet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

Social Media Use in Chronic Disease: A Systematic Review and Novel Taxonomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0287-9

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

21 January 2018

1 reference

12 December 2020

Some speculations on the myeloproliferative syndromes.

1 reference

12 December 2020

A new model: physician-patient collaboration in online communities and the clinical practice of oncology.

1 reference

12 December 2020

The Role of Social Media in Promoting Women's Health Education in Saudi Arabia.

1 reference

12 December 2020

Using social media in oncology for education and patient engagement.

1 reference

12 December 2020

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

1 reference

12 December 2020

10.1007/S11899-015-0287-9

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

0 references

1 reference